Literature DB >> 12388233

Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart.

Arzu Onay-Besikci1, Fiona M Campbell, Teresa A Hopkins, Jason R B Dyck, Gary D Lopaschuk, Arzu Onay Besikci.   

Abstract

After birth, a dramatic increase in fatty acid oxidation occurs in the heart, which has been attributed to an increase in l-carnitine levels and a switch from the liver (L) to muscle (M) isoform of carnitine palmitoyltransferase (CPT)-1. However, because M-CPT-1 is more sensitive to inhibition by malonyl CoA, a potent endogenous regulator of fatty acid oxidation, a switch to the M-CPT-1 isoform should theoretically decrease fatty acid oxidation. Because of this discrepancy, we assessed the contributions of myocardial l-carnitine content and CPT-1 isoform expression and kinetics to the maturation of fatty acid oxidation in newborn rabbit hearts. Although fatty acid oxidation rates increased between 1 and 14 days after birth, myocardial l-carnitine concentrations did not increase. Changes in the expression of L-CPT-1 or M-CPT-1 mRNA after birth also did not parallel the increase in fatty acid oxidation. The K(m) of CPT-1 for carnitine and the IC(50) for malonyl CoA remained unchanged between 1 and 10 days after birth. However, malonyl CoA levels dramatically decreased, due in part to an increase in malonyl CoA decarboxylase activity. Our data suggest that a decrease in malonyl CoA control of CPT-1 is primarily responsible for the increase in fatty acid oxidation seen in the newborn heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388233     DOI: 10.1152/ajpheart.00461.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

Review 1.  Regulation of cardiac energy metabolism in newborn.

Authors:  Arzu Onay-Besikci
Journal:  Mol Cell Biochem       Date:  2006-05-03       Impact factor: 3.396

Review 2.  Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.

Authors:  Andrew N Carley; Heinrich Taegtmeyer; E Douglas Lewandowski
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

Review 3.  Metabolic reserve of the heart: the forgotten link between contraction and coronary flow.

Authors:  Christos Kassiotis; Mitra Rajabi; Heinrich Taegtmeyer
Journal:  Prog Cardiovasc Dis       Date:  2008 Jul-Aug       Impact factor: 8.194

Review 4.  Return to the fetal gene program protects the stressed heart: a strong hypothesis.

Authors:  Mitra Rajabi; Christos Kassiotis; Peter Razeghi; Heinrich Taegtmeyer
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

5.  Systematic Evaluation of Key L-Carnitine Homeostasis Mechanisms during Postnatal Development in Rat.

Authors:  Binbing Ling; Caroline Aziz; Jane Alcorn
Journal:  Nutr Metab (Lond)       Date:  2012-07-17       Impact factor: 4.169

6.  Timing and Duration of Drug Exposure Affects Outcomes of a Drug-Nutrient Interaction During Ontogeny.

Authors:  Binbing Ling; Caroline Aziz; Chris Wojnarowicz; Andrew Olkowski; Jane Alcorn
Journal:  Pharmaceutics       Date:  2010-10-14       Impact factor: 6.321

7.  In utero exposure to diesel exhaust is associated with alterations in neonatal cardiomyocyte transcription, DNA methylation and metabolic perturbation.

Authors:  Jamie M Goodson; James W MacDonald; Theo K Bammler; Wei-Ming Chien; Michael T Chin
Journal:  Part Fibre Toxicol       Date:  2019-04-11       Impact factor: 9.400

8.  PHDs/CPT1B/VDAC1 axis regulates long-chain fatty acid oxidation in cardiomyocytes.

Authors:  Aude Angelini; Pradip K Saha; Antrix Jain; Sung Yun Jung; Randall L Mynatt; Xinchun Pi; Liang Xie
Journal:  Cell Rep       Date:  2021-10-05       Impact factor: 9.423

9.  Cardiac PPARalpha Protein Expression is Constant as Alternate Nuclear Receptors and PGC-1 Coordinately Increase During the Postnatal Metabolic Transition.

Authors:  Norman E Buroker; Xue-Han Ning; Michael Portman
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.